恩度联合化疗治疗晚期非小细胞肺癌的疗效和安全性

Effi cacy and Safety of Endostar Combined with Chemotherapy on Advanced Non-Small Cell Lung Cancer

目的探讨恩度联合化疗治疗晚期非小细胞肺癌疗效和安全性。方法选取本院接受治疗的100例非小细胞肺癌患者,按照入院顺序分成两组,观察组采用恩度联合化疗治疗,对照组采用常规化疗治疗。观察对比两组治疗效果。结果观察组治疗有效率为96.0%,显著高于对照组的84.0%(P<0.05);观察组的药物不良反应发生率为4.0%,低于对照组的8.0%(P>0.05)。结论晚期非小细胞肺癌的治疗中采用恩度联合化疗治疗方案具有较高的治疗有效率且患者的用药不良反应发生率也较低。

Objective To investigate the efficacy and safety of Endostar combined with chemotherapy on advanced non-small cell lung cancer. Methods Totally 100 cases of non small cell lung cancer treated in our hospital were divided into two groups according to the order of admission. The observation group was treated with Endostar combined with chemotherapy,the control group was treated with chemotherapy. Treatment effect was compared between groups. Results The effective rate of the observation group was 96.0%,which was higher than that of the control group(84.0%,P<0.05). The incidence of adverse drug reactions in the observation group was 4.0%,lower than that of the control group(8.0%,P>0.05). Conclusion Endostar combined with chemotherapy on advanced non-small cell lung cancer with high effective and the incidence of adverse drug reactions is low.